These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 34479542)

  • 21. Pharmacists views on participating in New Zealand's community pharmacy anticoagulation management service: a mixed-methods study.
    Beyene K; Chan AHY; Barton E; Yan S; Singh S; Basani A; Voong J; Harrison J
    Int J Clin Pharm; 2021 Feb; 43(1):251-262. PubMed ID: 32920685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep health management in community pharmacy: Where are we and where should we be heading?
    Basheti MM; Gordon C; Bawa Z; Grunstein R; Saini B
    Res Social Adm Pharm; 2021 Nov; 17(11):1945-1956. PubMed ID: 33602626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
    Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
    BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intervention research to enhance community pharmacists' cognitive services: a systematic review.
    Patwardhan PD; Amin ME; Chewning BA
    Res Social Adm Pharm; 2014; 10(3):475-93. PubMed ID: 24071523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London.
    Hesso I; Kayyali R; Nabhani-Gebara S
    BMC Health Serv Res; 2019 Jan; 19(1):5. PubMed ID: 30611264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital pharmacists' ethical exposure and decision-making.
    So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL
    Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
    Fathima M; Saini B; Foster JM; Armour CL
    Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan.
    Almansour HA; Chaar B; Saini B
    Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing pharmacy services in opioid substitution treatment.
    Chaar BB; Wang H; Day CA; Hanrahan JR; Winstock AR; Fois R
    Drug Alcohol Rev; 2013 Jul; 32(4):426-34. PubMed ID: 23442133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight management in community pharmacy: what do the experts think?
    Um IS; Armour C; Krass I; Gill T; Chaar BB
    Int J Clin Pharm; 2013 Jun; 35(3):447-54. PubMed ID: 23456174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolving profile of cognitive pharmaceutical services in Australia.
    Tong V; Krass I; Luckie K; Aslani P
    Res Social Adm Pharm; 2022 Mar; 18(3):2529-2537. PubMed ID: 33992586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related stakeholders' perceptions of clinical pharmacy services in Qatar.
    Jebara T; Cunningham S; MacLure K; Awaisu A; Pallivalapila A; Al Hail M; Stewart D
    Int J Clin Pharm; 2021 Feb; 43(1):107-117. PubMed ID: 32960428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists.
    Czarniak P; Chalmers L; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B; Sim TF
    Int J Clin Pharm; 2022 Apr; 44(2):466-479. PubMed ID: 35088232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacists' perspectives and attitudes towards the 2021 down-scheduling of melatonin in Australia using the Theoretical Domains Framework: a mixed-methods study.
    Yeung KWCM; Lee SKM; Bin YS; Cheung JMY
    Int J Clin Pharm; 2023 Oct; 45(5):1153-1166. PubMed ID: 37354280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.